Josh Tarasoff
Greenlea Lane Capital Management
Josh Tarasoff Brookfield Corp stake
total: 26
Greenlea Lane Capital Management BN trades
- Total transactions:
- 26
- New positions:
- 1
- Added:
- 13
- Reduced:
- 12
- Held since:
- 2018 Q4
- Held for:
- 30 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Josh Tarasoff holds 1,392,742 Brookfield Corp (BN) shares with a market value of roughly $56.36M accounting for 16.37% of the overall portfolio. To date, the estimated cost basis is nearly $34.46 for "buy" trades and estimated average "sell" price is $46.49. Greenlea Lane Capital Management first purchased BN in 2018 Q4, initially acquiring 826,425 shares. Since the initial investment in Brookfield Corp (BN), Greenlea Lane Capital Management has made 25 more transactions.
When did Josh Tarasoff buy Brookfield Corp (BN)?
Josh Tarasoff first invested in Brookfield Corp (BN) in 2018 Q4 at the reported quarter-end price of $25.57 per share.
What's the cost basis of Greenlea Lane Capital Management's BN stake?
The estimated cost basis for Brookfield Corp (BN) stake is around $34.46 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $34.46
- Weighted AVG sell price:
- $46.49
Josh Tarasoff's historical trades in Brookfield Corp
26 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
16.37%
|
1,392,742
|
$40.47
|
$56,364,269
|
-1.47% (-20,720)
|
-0.24%
|
|
2025 Q4
|
18.93%
|
1,413,462
|
$45.89
|
$64,863,771
|
+48.44% (+461,247)
|
+6.18%
|
|
2025 Q2
|
16.57%
|
952,215
|
$61.85
|
$58,894,498
|
-1.57% (-15,210)
|
-0.33%
|
|
2025 Q1
|
17.52%
|
967,425
|
$52.41
|
$50,702,744
|
-2.76% (-27,470)
|
-0.43%
|
|
2024 Q4
|
17.23%
|
994,895
|
$57.45
|
$57,156,718
|
-3.98% (-41,220)
|
-0.72%
|
|
2024 Q3
|
16.71%
|
1,036,115
|
$53.15
|
$55,069,512
|
-33.03% (-511,020)
|
-7.41%
|
|
2024 Q1
|
18.35%
|
1,547,135
|
$41.87
|
$64,778,542
|
-4.22% (-68,085)
|
-0.88%
|
|
2023 Q4
|
20.07%
|
1,615,220
|
$40.12
|
$64,802,626
|
+3.54% (+55,211)
|
+0.69%
|
|
2023 Q3
|
17.48%
|
1,560,009
|
$31.27
|
$48,781,481
|
+19.15% (+250,779)
|
+2.81%
|
|
2023 Q2
|
16.07%
|
1,309,230
|
$33.65
|
$44,055,590
|
+38.75% (+365,630)
|
+4.49%
|
|
2022 Q4
|
14.13%
|
$31.46
|
+7.44% (+65,310)
|
|||
|
2022 Q3
|
13.06%
|
$40.89
|
+0.63% (+5,525)
|
|||
|
2022 Q2
|
15.45%
|
$44.47
|
-7.58% (-71,623)
|
|||
|
2022 Q1
|
14.88%
|
$56.57
|
+3.28% (+30,012)
|
|||
|
2021 Q4
|
17.91%
|
$60.38
|
+4.99% (+43,440)
|
|||
|
2021 Q3
|
15.23%
|
$53.51
|
+11.79% (+91,855)
|
|||
|
2021 Q2
|
11.92%
|
$50.98
|
-21.04% (-207,625)
|
|||
|
2021 Q1
|
18.40%
|
$44.50
|
-2.62% (-26,545)
|
|||
|
2020 Q4
|
15.65%
|
$41.27
|
+8.41% (+78,573)
|
|||
|
2020 Q3
|
11.89%
|
$33.06
|
+21.09% (+162,801)
|
|||
|
2020 Q2
|
12.13%
|
$32.90
|
-12.28% (-108,015.5)
|
|||
|
2020 Q1
|
17.04%
|
$29.50
|
-15.26% (-158,430)
|
|||
|
2019 Q4
|
19.90%
|
$38.53
|
-4.50% (-48,982.5)
|
|||
|
2019 Q2
|
19.05%
|
$31.85
|
+5.61% (+57,780)
|
|||
|
2019 Q1
|
19.04%
|
$31.10
|
+24.58% (+203,100)
|
|||
|
2018 Q4
|
20.56%
|
$25.57
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.